Fiasp 100IU/ml Solution for injection is used for blood sugar control in individuals who have been diagnosed with type 1 and type 2 diabetes. It helps lower blood sugar levels after meals. Further, it reduces the chance of developing any diabetes complications, including kidney damage, nerve problems, loss of limbs, or eye damage.
Your doctor may prescribe Fiasp 100IU/ml Solution be used with a long-acting type of insulin or other medications for diabetes.
Fiasp (insulin aspart) vials are fast-acting insulin that closely matches the natural physiological insulin produced after a meal by a person who does not have diabetes. To increase the speed of absorption, Fiasp has included Vitamin B3 (niacinamide) as it is also used for stability, L-Argenine, a natural amino acid.
Unlike other common brands of insulin, Fiasp has a more flexible dosing regimen that allows you to inject up to 2 minutes before starting a meal or up to 20 minutes after starting a meal without compromising your overall safety and glycemic control.
Ensure you are ordering the correct insulin, as insulin aspart is available by Novolin in pens, vials and cartridges.
Usage
Your physician or nurse will instruct you to inject it subcutaneously (under the skin) properly.
Fiasp insulin should be taken 15 minutes before your meal or within 20 minutes of starting a meal. It is essential to monitor your blood glucose levels regularly and keep track of results. Please share your results with your doctor so they can prescribe the correct dose that works for you.
Unless your doctor tells you otherwise, do not stop taking this medication.
Taking this diabetes medication should be part of your treatment, and a healthy diet, exercise program, and weight loss plan as advised by your doctor.
Pump or infusion set malfunctions can potentially lead to a rapid onset of hyperglycemia or ketoacidosis. Interim therapy with subcutaneous injection of Fiasp may be required. Patients using continuous subcutaneous insulin infusion pump therapy must be trained to administer insulin by injection and have alternate insulin therapy available in case of a pump failure.
Patients should rotate injection areas to avoid lipodystrophy or localized cutaneous amyloidosis.
Side Effects
The most common side effect related to Fiasp is hypoglycemia which in some cases may be life-threatening.
– Heart failure and fluid retention may occur with the concomitant use of thiazolidinediones (TZDs). Dosage reduction or discontinuation may be recommended if any severe symptoms or complications such as heart failure are experienced.
– As with other insulins, the use of Fiasp insulin can lead to other life-threatening hypokalemia, which may cause ventricular arrhythmia, paralysis, and even death. It’s important to monitor potassium levels to prevent hypokalemia and consult your physician if treatment is necessary.
– Infusion set or pump malfunctions can lead to ketoacidosis or rapid onset of hyperglycemia.
– Other adverse reactions may include allergic reactions, injection site reactions, weight gain, lipodystrophy, rash, pruritus, and hypoglycemia.
Reviews
There are no reviews yet.